Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

When Medical Management Fails Graves' Disease Patients, Surgery is the Only Option

Clayman Thyroid Center logo (PRNewsfoto/Clayman Thyroid Center)

News provided by

Clayman Thyroid Center

Jul 08, 2022, 09:10 ET

Share this article

Share toX

Share this article

Share toX

TAMPA, Fla., July 8, 2022 /PRNewswire/ -- According to the American Thyroid Association, July is Graves' Disease Awareness Month. Graves' Disease is an autoimmune disease that affects the thyroid gland and is the most common cause of overproduction of thyroid hormone within the body (hyperthyroidism).

Continue Reading
The Clayman Thyroid Center team at the Hospital for Endocrine Surgery in Tampa, Florida recognizes Graves' Disease Awareness Month, July 2022.
The Clayman Thyroid Center team at the Hospital for Endocrine Surgery in Tampa, Florida recognizes Graves' Disease Awareness Month, July 2022.

In Graves' Disease, the body's immune system for some reason turns against a part or parts of the thyroid. Graves' Disease symptoms include unexplained weight loss, heat intolerance or excessive sweating, anxiety, tremors, restlessness, difficulty sleeping at night, rapid or irregular heart rate, palpitations or chest pain, difficulty breathing or shortness of breath, goiter or thyroid mass, prominent bulging eyes, blurred vision, double vision, muscle weakness, change in menstrual periods, increased frequency of bowel movements and more.

There are several different approaches in the management of Graves' Disease. These include medical management with anti-thyroid medication, radioactive iodine therapy, and thyroid surgery.

Surgery for Graves' Disease is the only 100% effective therapy. Surgery for Grave's Disease requires total removal of the thyroid gland. When the Graves' thyroid gland is very large, thyroid surgery is widely considered the preferred treatment. It is also the best treatment option when other treatments have been ineffective or if a patient cannot tolerate another form of treatment. This surgery should only be performed by expert thyroid surgeons and managed by an expert thyroid surgery team.

"Many patients don't do well with medical therapies for Graves' Disease," said Dr. Gary Clayman of the Clayman Thyroid Center. "Often their disease becomes difficult to consistently control and they can experience roller coaster symptoms of very high thyroid hormone levels followed by periods of very low thyroid hormone production. After a period of treatment, many patients get exhausted by these roller coaster hormone rides and seek surgery for Graves' Disease."

What is most important in the treatment of Graves' Disease is choosing the right treatment that best suits each individual patient. Surgery for Graves' Disease may be the best treatment for many patients and can be accomplished through several different approaches. Surgery for Graves' Disease may include minimally invasive thyroid surgery, robotic thyroid surgery which does not produce a neck incision as well as transoral thyroid surgery which uses an incision within the mouth. The best surgery for Graves' Disease requires the safe removal of the entire thyroid gland no matter which approach is chosen.

"Just this week I saw a patient who was diagnosed with Graves' Disease several years ago," said Dr. Rashmi Roy of the Clayman Thyroid Center. "She was trying to manage her disease with several medications, none of which were working for her. While trying these medications, her thyroid grew substantially, and she developed a large Graves' goiter in her neck as well as Graves' eye disease. Because her goiter was so large, she was suffering with significant symptoms including difficulty breathing, swallowing and speaking. I removed her thyroid gland with an operation that lasted about an hour. She spent some time in recovery and was discharged the following day without any complications. If you have Graves' Disease and medical management is failing you, please consider surgery. It's the best option for your recovery."

Founded by Dr. Clayman, the Clayman Thyroid Center is widely recognized as America's leading thyroid surgery center, performing nearly 2,000 thyroid operations annually. Patients from all over the world travel to Tampa to have their operation performed by the Clayman Thyroid Center's surgeons at the brand-new Hospital for Endocrine Surgery. The Clayman Thyroid Center is a full-service thyroid surgery center, offering the most advanced forms of thyroid surgery for all types of thyroid tumors, from small thyroid nodules to large Graves' goiters and complex thyroid cancer.

The Clayman Thyroid Center's philosophy centers on a customized surgery plan for every single patient which includes:

  • Complete and extensive ultrasound examination
  • Ability to biopsy even the smallest nodules or lymph nodes
  • Consultation regarding every option for your specific thyroid disease
  • Expertise in complex thyroid diseases
  • Expertise in robotic thyroid surgery that leaves no neck scar
  • Surgeons work as a team to assure highest cure rates and best outcomes
  • Highest volume, most experienced thyroid surgeons in America

"I am not one to fully trust testimonials, but I have to tell my story," said Carol, a recent patient at the Clayman Thyroid Center. "I was diagnosed with Graves' disease and had a long-distance phone consultation with Drs Clayman and Roy regarding my thyroid surgery. On the way to Tampa, I told my husband I was prepared to "just be a number" in the surgery process. Wow, I couldn't have been more wrong. It is amazing how individualized this treatment made me feel during this trying time. I cannot say enough amazing things about how I was made to feel and the level of treatment I was given. These people and this place are absolutely amazing. Not that I would wish this surgery on anyone, but if you need thyroid surgery, there is only one place to go."

About the Clayman Thyroid Center:

Founded by one of the nation's best-known thyroid surgeons, the Clayman Thyroid Center is the highest volume thyroid cancer referral center in the United States. The Center boasts the most experienced thyroid surgeons in the US who provide personalized care allowing the greatest opportunity for cancer cure, wellness, and cosmetic and functional outcomes via all types of thyroid surgery from minimal incision to scarless thyroid surgery to advanced cancer care.

www.thyroidcancer.com | (813) 940-3130

Media Contact: Julie Canan, [email protected] 

SOURCE Clayman Thyroid Center

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Clayman Thyroid Center Launches Inaugural Hashimoto's Disease Awareness Day on March 12

Clayman Thyroid Center Launches Inaugural Hashimoto's Disease Awareness Day on March 12

The Clayman Thyroid Center is proud to announce the launch of Hashimoto's Disease Awareness Day, to be observed annually on the second Wednesday in...

More Releases From This Source

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.